Literature DB >> 19538102

Diabetes medications and body weight.

Joanna Mitri1, Osama Hamdy.   

Abstract

Tight diabetes control sometimes comes with a price: weight gain and hypoglycemia. Two of the three major recent trials that looked at the relationship between intensive diabetes control and cardiovascular events reported significant weight gain among the intensively treated groups. There is a growing concern that the weight gain induced by most diabetes medications diminishes their clinical benefits. On the other hand, there is a claim that treating diabetes with medications that are weight neutral or induces weight loss or less weight gain while minimizing those that increase body weight may emerge as the future direction for treating overweight and obese patients with diabetes. This review clarifies the weight effect of each of the currently available diabetes medications, and explains the mechanism of action behind this effect. Despite the great variability among reviewed clinical trials, the currently available evidence is quite sufficient to demonstrate the change in body weight in association with most of the currently available medications. This review also provides some guidelines on using diabetes medications during weight management programs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538102     DOI: 10.1517/14740330903081725

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  36 in total

1.  Nonsurgical diabetes weight management: be prepared for sustainable and practical interventions.

Authors:  Osama Hamdy
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

2.  Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.

Authors:  Jacob D Brown; Danielle McAnally; Jennifer E Ayala; Melissa A Burmeister; Camilo Morfa; Layton Smith; Julio E Ayala
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-27       Impact factor: 3.619

Review 3.  Behavioural implications of traditional treatment and closed-loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework.

Authors:  A R Kahkoska; E J Mayer-Davis; K K Hood; D M Maahs; K S Burger
Journal:  Diabet Med       Date:  2017-09-11       Impact factor: 4.359

Review 4.  Antidiabetic plant-derived nutraceuticals: a critical review.

Authors:  Jayapal Naveen; Vallikannan Baskaran
Journal:  Eur J Nutr       Date:  2017-10-11       Impact factor: 5.614

5.  Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Celine Valant; Rohan Sridhar; Owen L Woodman; Laurence J Miller; Roger J Summers; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2010-06-14       Impact factor: 4.436

Review 6.  Weight management using a meal replacement strategy in type 2 diabetes.

Authors:  Osama Hamdy; Debbie Zwiefelhofer
Journal:  Curr Diab Rep       Date:  2010-04       Impact factor: 4.810

Review 7.  Cardiovascular effects of gliptins.

Authors:  André J Scheen
Journal:  Nat Rev Cardiol       Date:  2013-01-08       Impact factor: 32.419

Review 8.  Lactic acidosis induced by metformin: incidence, management and prevention.

Authors:  Jean-Daniel Lalau
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

9.  The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Authors:  Saira Khan; Jianwen Cai; Matthew E Nielsen; Melissa A Troester; James L Mohler; Elizabeth T H Fontham; Laura H Hendrix; Laura Farnan; Andrew F Olshan; Jeannette T Bensen
Journal:  Cancer Causes Control       Date:  2016-11-09       Impact factor: 2.506

10.  Evaluation of the association between the AC3 genetic polymorphisms and obesity in a Chinese Han population.

Authors:  Hairu Wang; Ming Wu; Weiguang Zhu; Jin Shen; Xiaoming Shi; Jie Yang; Qihui Zhao; Chuan Ni; Yaochu Xu; Hongbing Shen; Chong Shen; Harvest F Gu
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.